OSMOTICA PHARMACEUTICALS PLC (RVLPQ)
Institutional ownership reported to the SEC as of Q4 2023, across 21 quarters.
2
Reporting holders
$613
Reported value
0.0%
Held as options
-24
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| XTX Topco Ltd | $542 | 180,566 | 0.00% | new | NEW |
| RAYMOND JAMES & ASSOCIATES | $71 | 23,696 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2023 | 2 | $613 | 204,262 | 2 | 0 | 0 | 0.0% |
| Q3 2023 | 26 | $1.5M | 16,981,435 | 6 | 6 | 3 | 0.0% |
| Q2 2023 | 35 | $13.1M | 23,389,570 | 2 | 3 | 12 | 0.0% |
| Q1 2023 | 38 | $27.9M | 24,313,854 | 6 | 3 | 8 | 0.5% |
| Q4 2022 | 31 | $26.7M | 23,784,712 | 1 | 9 | 5 | 0.6% |
| Q3 2022 | 47 | $51.1M | 24,041,872 | 17 | 5 | 7 | 1.1% |
| Q2 2022 | 35 | $22.3M | 16,363,943 | 5 | 4 | 10 | 0.4% |
| Q1 2022 | 35 | $27.9M | 16,443,593 | 10 | 8 | 6 | 0.4% |
| Q4 2021 | 30 | $18.7M | 17,305,135 | 8 | 6 | 10 | 0.2% |
| Q3 2021 | 34 | $11.9M | 4,032,072 | 1 | 12 | 12 | 0.0% |
| Q2 2021 | 44 | $14.5M | 4,827,407 | 10 | 6 | 21 | 0.0% |
| Q1 2021 | 54 | $25.7M | 7,875,173 | 8 | 18 | 15 | 0.0% |
| Q4 2020 | 60 | $31.0M | 7,520,170 | 6 | 22 | 21 | 0.0% |
| Q3 2020 | 62 | $45.1M | 8,327,597 | 13 | 26 | 13 | 0.0% |
| Q2 2020 | 65 | $41.0M | 6,099,789 | 16 | 26 | 16 | 0.0% |
| Q1 2020 | 61 | $25.6M | 7,431,878 | 19 | 25 | 12 | 0.0% |
| Q4 2019 | 50 | $25.6M | 3,656,127 | 14 | 22 | 8 | 0.0% |
| Q3 2019 | 39 | $7.3M | 1,903,652 | 6 | 15 | 10 | 0.0% |
| Q2 2019 | 42 | $13.6M | 3,572,070 | 14 | 11 | 11 | 0.0% |
| Q1 2019 | 34 | $21.6M | 5,995,602 | 7 | 9 | 11 | 0.0% |
| Q4 2018 | 34 | $51.6M | 6,660,019 | 3 | 0 | 0 | 0.0% |